Amneal Pharmaceuticals Financial Overview
Amneal Pharmaceuticals's market cap is currently $3.88B. The company's EPS TTM is $0.17; its P/E ratio is 890.14; Amneal Pharmaceuticals is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.18. See an overview of income statement, balance sheet, and cash flow financials.
